Sales and Marketing

Showing 15 posts of 11524 posts found.

Pharma Brands – join the live discussion on Twitter

October 17, 2011 Sales and Marketing branding, brands

Do pharma marketers need to kill off the ‘smiley happy people’ and update their approach to branding?  InPharm will host …
Roche

Roche buys US firm Anadys for $230 million

October 17, 2011 Research and Development, Sales and Marketing Roche, hepatitis C

Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …

Russian diabetes market to grow to $1.7 billion

October 17, 2011 Sales and Marketing Russia, diabetes

Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …

Health service’s £1bn patent expiry windfall

October 14, 2011 Sales and Marketing generics, patent expiry

Patent expiries could shave £1 billion from  the NHS drugs bill, and could yield major savings by 2015 for the …

Pfizer to research prescription drug costs for the elderly

October 14, 2011 Sales and Marketing Pfizer

Pfizer has signed a five-year research pact with US healthcare insurer Humana to investigate treatment costs for the elderly. The …
Yervoy

NICE: Bristol-Myers Squibb’s Yervoy too costly

October 14, 2011 Sales and Marketing NICE, Yervoy

Bristol Myers Squibb has failed to win NICE backing for its melanoma drug Yervoy after the Institute judged its £80,000 …
Avastin

NHS regions back Avastin for eye disease

October 14, 2011 Sales and Marketing avastin

Regional NHS authorities around England are approving the use of Avastin instead of Lucentis for ophthalmology patients. A number of …
Kindle Fire

Keep taking the tablets

October 13, 2011 Sales and Marketing ipad, tablet pc

Online giant Amazon has just launched Fire, its rival to Apple’s trendsetting iPad, upping the ante in the ‘tablet’ market. …
Roche

Roche revenue drops as key products underperform

October 13, 2011 Sales and Marketing Roche

Roche has posted worse-than-expected figures for the first nine months of this year after key products failed to shine and …

NICE recommends RoActemra for early use in arthritis

October 13, 2011 Sales and Marketing NICE, RoActemra

NICE has recommended Roche’s drug RoActemra be used at an earlier stage for some arthritis patients. In draft guidance NICE …
Europe

Pharmacovigilance at heart of EC patient information proposals

October 12, 2011 Medical Communications, Sales and Marketing patient information

Pharmacovigilance is at the centre of revised proposals announced this week setting out what information pharma firms can put on …

Charities support new electronic patient records

October 12, 2011 Sales and Marketing IT, NHS, electronic patient records

The troubled project to launch an NHS-wide electronic patient record system has received new support from patient groups.The Summary Care …
India

India will scrutinise foreign investment in pharma

October 11, 2011 Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry

The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …
Victoza

Novo Nordisk’s Victoza launched in China

October 10, 2011 Sales and Marketing Byetta, China, Victoza, diabetes

Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …

US approval for Merck’s Januvia-Zocor combination

October 10, 2011 Sales and Marketing Januvia, Juvisync, Zocor

US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …
The Gateway to Local Adoption Series

Latest content